COX-2 inhibitors arrest prostate cancer cell cycle progression by down-regulation of kinetochore/centromere proteins.
about
Evidence to Support the Anti-Cancer Effect of Olive Leaf Extract and Future DirectionsAssessment of a prognostic model, PSA metrics and toxicities in metastatic castrate resistant prostate cancer using data from Project Data Sphere (PDS)Targeting Cdc20 as a novel cancer therapeutic strategy.Omega-3 Fatty Acid Consumption and Prostate Cancer: A Review of Exposure Measures and Results of Epidemiological Studies.Downregulated microRNA-26a modulates prostate cancer cell proliferation and apoptosis by targeting COX-2Derivation and Evaluation of Putative Adverse Outcome Pathways for the Effects of Cyclooxygenase Inhibitors on Reproductive Processes in Female Fish.Nonsteroidal anti-inflammatory drugs, statins, and pancreatic cancer risk: a population-based case-control study.Correlation between Oxidative Stress, Nutrition, and Cancer Initiation.Global gene expression analysis combined with a genomics approach for the identification of signal transduction networks involved in postnatal mouse myocardial proliferation and development.Expression of prostaglandin E2 and EP receptors in human papillary thyroid carcinoma.Inhibition of cyclooxygenase-2-mediated matriptase activation contributes to the suppression of prostate cancer cell motility and metastasis.Altered primary chromatin structures and their implications in cancer development.Short hairpin RNA-mediated down-regulation of CENP-A attenuates the aggressive phenotype of lung adenocarcinoma cells.Efficacy of metronomic oral cyclophosphamide with low dose dexamethasone and celecoxib in metastatic castration-resistant prostate cancer.Bioinformatic analysis of prognostic value of ZW10 interacting protein in lung cancer.
P2860
Q26739934-F0F0C54F-9A38-4697-BCED-06EA5E66B8B4Q30000285-8BEEB80F-6D51-4528-9F06-DD6532BDF473Q35688708-F5BF1CC7-A106-4BCF-A6B0-B0B3273A71B1Q38643709-6E3C508C-11E7-475A-A0F1-5741E767771DQ38789206-A3062A0C-6336-4943-9684-C381B58C3F31Q38959910-D05D7E95-3E04-4435-91D3-696BC5531164Q39211871-40C9934C-3DEF-40D0-805F-D5601A8F1077Q39438812-D949D1A7-FCFC-42D1-B4C4-6947F54E0EBBQ47137479-1F0CEF84-7F68-4C5D-BC29-A98CBADB67F8Q47976968-B1CACFE6-A753-4AB8-B860-A3DC62518902Q51075784-EF47AD50-3E82-48BF-99F7-A4012CA41EF9Q52878923-E149138A-7E4D-4C83-9F54-89202A419F8EQ53019370-AF80B18E-6424-4285-A624-46F0670C8755Q53037084-C4F36F03-1E79-4585-9995-5EF21DAA5D3CQ54959928-B757EC4C-67E3-47A0-BCCA-44996DE6A242
P2860
COX-2 inhibitors arrest prostate cancer cell cycle progression by down-regulation of kinetochore/centromere proteins.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
COX-2 inhibitors arrest prosta ...... netochore/centromere proteins.
@en
type
label
COX-2 inhibitors arrest prosta ...... netochore/centromere proteins.
@en
prefLabel
COX-2 inhibitors arrest prosta ...... netochore/centromere proteins.
@en
P2093
P2860
P356
P1433
P1476
COX-2 inhibitors arrest prosta ...... netochore/centromere proteins.
@en
P2093
Chandra Childress
Jared Bieniek
Matthew D Swatski
Wannian Yang
P2860
P304
P356
10.1002/PROS.22815
P577
2014-05-07T00:00:00Z